Q2 2021 Bergenbio ASA Earnings Call Transcript
Ladies and gentlemen, welcome to BerGenBio conference call for the first half of 2021. I will now hand the word over to the speakers. Please go ahead.
Thank you, and good morning. This is Richard Godfrey, CEO of BerGenBio. Welcome to our half 1 quarter 2 report and highlights and financials for 2021. I'm joined this morning by Rune Skeie, our CFO. Next slide, please.
Firstly, may I draw your attention to our forward-looking statements and the safe harbor comments. As we are a publicly-traded company, it's important that these are beared in mind. Thank you. Next slide, please.
Here is a schedule of some of the topics I'd like to cover during this morning's presentation. Next slide, please.
On Slide 4, I thought I'd provide a brief snapshot of the first half of 2021 and quarter 2. I guess it's important when reviewing our company's performance to remember that we're still coming out of, or indeed arguably still in, the pandemic of COVID-19. And although our company, as many have made operational
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |